Myeloid neoplasms with concurrent BCR-ABL1 and CBFB rearrangements: A series of 10 cases of a clinically aggressive neoplasm

Chronic myeloid leukemia (CML) is defined by the presence of t(9;22)(q34;q11.2)/BCR-ABL1. Additional chromosomal abnormalities confer an adverse prognosis and are particularly common in the blast phase of CML (CML-BP). CBFB rearrangement, particularly CBFB-MYH11 fusion resulting from inv(16)(p13.1q2...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Am J Hematol
Auteurs principaux: Salem, Alireza, Loghavi, Sanam, Tang, Guilin, Huh, Yang O., Jabbour, Elias J., Kantarjian, Hagop, Wang, Wei, Hu, Shimin, Luthra, Rajyalakshmi, Medeiros, L. Jeffrey, Khoury, Joseph D.
Format: Artigo
Langue:Inglês
Publié: 2017
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5860811/
https://ncbi.nlm.nih.gov/pubmed/28253536
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24710
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires